Asian Venture Capital Journal (AVCJ)
KKR has agreed to buy a 54% stake in Indian drug maker J.B. Chemicals & Pharmaceuticals for INR31.1 billion ($416 million) and made an open offer for an additional 26% of the company.
China-based data storage software services provider XSKY has raised a RMB320 million ($45 million) Series D led by China's State Owned Capital Venture Capital Fund.
CF PharmTech, a Chinese medical devices maker focused on innovative respiratory products, has raised a $50 million Series F round with support from CICC Capital.
Frustrated with his business, Sebastian Togelang returned to Indonesia from Germany to invest in technology start-ups. He counsels entrepreneurs that it pays to be part of a larger platform
Korea Investment Corporation (KIC) has promoted Jong-ho Kim from head of private equity to deputy CIO with a brief to lead its alternative investment group.
UK development finance institution CDC Group has appointed Rabi Rayamajhi as its first country representative for Nepal.